Global Radiation Therapy in the Oncology Market - 1-3 USERS:2021

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2031 - Start Value : $5,647.7 Million in 2021 - Forecast Value : $9,206.6 Million by 2031 - CAGR % : 0.05%
Description :
Market Report Coverage - Radiation Therapy in the OncologyMarket Segmentation• Radiation – External Beam Radiation, Internal Beam Radiation• Product – Oncology Systems, Particle Therapy Systems (Proton and Heavy-Ion), Others• Therapy – Stereotactic Radiosurgery (SRS), Brachytherapy, Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Volumetric-Modulated Arc Therapy (VMAT)• End User – Hospitals & Medical Research Institutes, Specialized Radiotherapy Centers (SRCs)• Region – North America, Europe, Asia-Pacific, Rest-of-the-WorldRegional Segmentation• North America – U.S., Canada• Europe – Germany, France, Spain, U.K., Italy, Rest-of-Europe• Asia-Pacific – Japan, South Korea, India, China, Australia and New Zealand, Rest-of-Asia-Pacific• Rest-of-the-WorldMarket Growth Drivers• Rising Incidence and Prevalence of Neoplastic Patients and Elevating Geriatric Population• Rising Demand for Reduced Radiation Exposure During Radiotherapy• Technological Advancements in the Field of RadiotherapyMarket Challenges• High Cost of Radiotherapy Systems and their Associated Procedures• Highly Regulated Market due to the Use of RadiationMarket Opportunities• Development of Low-Cost Cancer Treatment Center• Implementation of Machine Learning in Radiotherapy SystemsKey Companies ProfiledAccuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Ltd.Who should buy this report?• Radiation Therapy Systems Parts OEMs • Accelerator Manufacturers • Radiation Therapy Systems Manufacturers • Software Developers • Imaging Modalities (MRI, CT, PET, Ultrasound, among others) ManufacturesKey questions answered in the Report• Which are the consortiums in the radiation therapy market, and what is their role in the market?• How is the funding scenario in the radiation therapy market?• What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?• What is the market trend within the radiation therapy systems industry?• What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?• How will the industry evolve during the forecast period 2021-2031?• What are the key developmental strategies implemented by the key players to sustain in the competitive market?• What is the current market share of each of the companies in the global radiation therapy in oncology market and what will be their contribution in 2031?• What is the growth potential of radiation therapy in oncology market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?• What are the key regulatory implications in developed and developing regions for radiation therapy systems and associated procedures?Radiation Therapy in Oncology Market OverviewRadiation therapy in the oncology market is a treatment method to treat any type of cancer/ tumor with the help of radiation. Radiation therapy uses radiation beams made of photon, proton, heavy-ion, and other particles. These radiation beams of intense energy are used to destroy or shrink the cancer/ tumor cells.The term ‘radiation therapy’ mostly refers to the external beam radiation therapy, but it also means internal beam radiation therapy too. The external beam radiation therapy is done with the help of a machine outside the patient’s body that produces high-energy radiation beam and then aims the beam to a localized precise point or area of treatment on the patient’s body. Whereas the internal beam radiation therapy is a method to place radiation (radioactive source) inside the patient’s body.The radiation therapy systems (machines) available in the market are, namely, linear accelerator (LINAC), cyclotrons, synchrotrons, synchrocyclotrons, and conventional and electronic brachytherapy systems.The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.0% during the forecast period from 2021 to 2031.Radiation Therapy Market DriversPresently, the factors driving the growth of the market as per the radiation therapy report include rising incidence and prevalence of neoplastic patients, elevating geriatric population, rising demand for reduced radiation exposure during radiotherapy, technological advancements in the field of radiotherapy.All the radiation therapy systems, such as external beam radiation systems or internal beam radiation systems are based on using radiation beam to treat cancer/tumor. The radiation beam destroys the cell’s DNA thus, resulting in the shrinkage or destruction of the cancer/ tumor. This cancer/ tumor treatment by radiation beam has resolved treatment of complex cancer/ tumor and providing less side effects when compared to traditional radiation therapy by x-ray or cobalt-60, or chemotherapy.Radiation Therapy Market ChallengesThe challenges that are restricting the growth of the market include high cost of radiotherapy systems and their associated procedures, and highly regulated market due to the use of radioactivity.High cost of the system and their associated procedures are among the most challenging factors for the end-user to buy and treatment delivery for patients. It has been observed that many patients prefer international travel for their treatment to take the advantage of currency rate. Also, due to the highly regulated market because of the use of the radioactivity have led the company to strictly obey the regulations to commercialize their products. Lack of accuracy in beam or radiation dose delivery is another factor affecting the growth of the global radiation therapy in oncology market.Radiation Therapy Market OpportunitiesPotential opportunities that is likely to boost the growth of the market include development of low-cost cancer treatment centers, developing radiation therapy system which is cost effective, and implementation of machine learning in radiation therapy system.The current radiation therapy systems have a price of more than $2 million, therefore many companies are working in developing cost-effective system and even working towards the development of a low-cost infrastructure facility for the radiation therapy. And with time, technologically advanced products are being working, researched to get an upgraded product.Impact of COVID-19 on Radiation Therapy MarketThe neoplastic patients were at concern with their need for timely diagnosis, treatment, and symptom palliation due to the pandemic lockdown. During the pandemic, there was an increased number of treatments for some cancers and on the other hand, some radiotherapy treatments fell significantly. The increase in the number of cancer treatments via radiation therapy was due to reduced surgical procedures, which lead the doctors to give radiation therapy as an alternative solution for the surgery.In response to safety from the COVID-19 virus. professional bodies internationally issued guidance for cancer care. The suggestions were treatment omission or delay, utilizing radiation therapy to replace or to bridge to surgery, and use of short and high-daily-dose (HDR or hypo-fractionated) radiotherapy.Market SegmentationRadiation Therapy Market (by Radiation Type)Under this segmentation, the radiation therapy market in divided into external beam radiation and internal beam radiation.The external beam radiation segment dominates the market with a share of 82.8% of global radiation therapy market mainly due to the more treatment processes being conducted by external beam radiation therapy systems.Internal beam radiation segment is expected to register a higher CAGR then external beam radiation segment, the CAGR is 6.7% during the forecast period.Radiation Therapy Market (by Product Type)Under this segmentation, the radiation therapy market in divided into oncology systems, particle therapy systems (proton and heavy-ion), and others.The oncology systems segment which consists traditional radiation therapy systems (x-ray, gamma, cobalt-60 external beam radiation therapy systems, and internal beam radiation therapy systems, among others) dominates the radiation therapy market with a share of 81.9% of global radiation therapy market mainly due to the number of installed bases of traditional systems and internal beam radiation therapy systems, number of procedures being conducted, and the cost of the systems and the procedure when compared with the proton or heavy-ion radiation therapy systems.Particle therapy systems (proton and heavy-ion) segment is expected to register a higher CAGR of 7.5% during the forecast period.Radiation Therapy Market (by Therapy)Under this segmentation, the radiation therapy market in divided into stereotactic radiosurgery (SRS), brachytherapy, image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT).The stereotactic radiosurgery (SRS) segment dominates the radiation therapy market with a share of 40% of global market mainly due to the number of procedures being performed by the surgeons and clinicians.Volumetric-modulated arc therapy segment is expected to register a higher CAGR of 6.8% during the forecast period.Radiation Therapy Market (by End-User)Under this segmentation, the radiation therapy market in divided into hospitals and medical research institutes, and specialized radiotherapy centers (SRCs).The hospitals and medical research institutes segment dominates the radiation therapy market with a share of 84.5% of global market mainly due to the number of hospitals, medical and research institutes providing access to the radiotherapy for the patients.Specialized radiotherapy centers (SRCs) segment is expected to register a higher CAGR of 6.2% during the forecast period.Radiation Therapy Market (by Region)The different regions covered under the radiation therapy in oncology market report includes North America, Europe, Asia-Pacific, and Rest-of-the-World.North America dominates the radiation therapy market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.Asia-Pacific market is expected to grow with a higher CAGR of 5.8% during the forecast period. Key Market Players and Competition SynopsisSome of the key players operating in the market, include Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Inc.The radiation therapy market market has witnessed several strategic and technological developments in the past four years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are product development and upgradations, partnerships, collaborations, business expansions, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been partnerships, collaborations, and business expansions.
Countries Covered :
North America U.S. CanadaEurope Germany Italy Spain France U.K. Rest-of-EuropeAsia-Pacific China Australia and New Zealand Japan India South Korea Rest-of-Asia-PacificRest-of-the-World
Keywords :
Radiation Therapy in the Oncology Market, Radiation Therapy in the Oncology Industry, Radiation Therapy in the Oncology Report, Radiation Therapy in the Oncology Market Forecasts, Radiation Therapy in the Oncology Market Trends, Radiation Therapy in the Oncology Market Companies, Radiation Therapy in the Oncology Market Analysis, Radiation Therapy in the Oncology Industry Analysis, What is Radiation Therapy in the Oncology, Radiation Therapy in the Oncology Definition, Radiation Therapy in the Oncology Market Competitive Landscape, Radiation Therapy in the Oncology Market Drivers, Radiation Therapy in the Oncology Market Segments, Radiation Therapy in the Oncology Market Outlook,Radiation Therapy in the Oncology Market Opportunity, Radiation Therapy in the Oncology Market Growth, Radiation Therapy in the Oncology Market Share, Radiation Therapy in the Oncology Market Size, Radiation Therapy in the Oncology Market by Application, Radiation Therapy in the Oncology Market by Product, Radiation Therapy in the Oncology Market by Region, Stereotactic Radiosurgery Therapy in the Oncology Market, Image-Guided Radiation Therapy in the Oncology Market, Intensity-Modulated Radiation Therapy in the Oncology Market, Volumetric-Modulated Arc Radiation Therapy in the Oncology Market, Hospitals and Medical Research Institutes Radiation Therapy in the Oncology Market, Specialized Radiotherapy Centers Radiation Therapy in the Oncology Market, Oncology Systems Radiation Therapy in the Oncology Market, Particle Therapy Systems Radiation Therapy in the Oncology Market, North America Radiation Therapy in the Oncology Market, Europe Radiation Therapy in the Oncology Market, Asia-Pacific Radiation Therapy in the Oncology Market
Press Release :
The global radiation therapy in oncology market is projected to reach $9,206.6 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.0% between 2021 and 2031.BIS Research study indicates that the global radiation therapy in oncology market has witnessed significant growth in the past ten years, owing to adoption of modern radiation therapy systems (proton and heavy-ion radiation therapy systems). Furthermore, advancement in radiation therapy systems for accurately delivering radiation dose to a particular localized treatment area, reducing radiation exposure to healthy tissue and organs, and various therapy procedures availability are some of the prominent factors expected to propel the growth of the radiation therapy in oncology market in the upcoming years.To emphasize the impact of COVID-19 on the global radiation therapy in oncology market, Abdul Wahid, AVP – BIS Research, states, "The COVID-19 pandemic transformed the treatment procedure, shifting from surgery to radiation therapy in possible cases. Also, the introduction of the modern radiation therapy systems such as proton or heavy-ion radiation therapy systems will witness accelerated growth in the radiation therapy market. The pandemic is expected to leave a long-term impact on the global radiation therapy in oncology market, along with the rising awareness of modern treatment availability and there benefits. Apart from the accelerated growth due to the COVID-19 pandemic and new radiation therapy systems, the radiation therapy in oncology market has been witnessing increasing radiotherapy treatment procedures and implementation of new innovation from new market entrants”.Leading companies, market participants, and vendors operating in the market, include, Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., and Zap Surgical Systems Inc., among others.Who should buy this report?• Radiation Therapy Systems manufacturers (emerging and established) to gain a holistic view about the market potential of various systems and software and the developing economies for business expansions.• Established healthcare companies that are integrating software, cloud platform, machine learning, AI, management software, and integrate able imaging modalities with radiation therapy systems manufacturers.• Established technology companies to gain insights about the market potential, market entry strategies, new technologies in the market, and key competitors.How can market intelligence on radiation therapy in oncology market add value to your business’s decision-making process?• Aid in product development.• Aid in understanding the regulatory scenario of the market in different regions.• Help in targeting a segment for launching a new product.• Aid in understanding market potential of different technologies.• Aid in understanding the end-user.• Support in analyzing the market opportunities.• Insights on the key companies in the market.Scope of the Global Radiation Therapy in Oncology Market Report:• Global trends • COVID-19 impact analysis • Available products, and end user segments and respective sub-divisions influencing the market • Study of more than 150 products present in the market.• Detailed competitive landscape• Detailed market share analysis• Study data of over 12 countries• Future perspective of the market• Growth factors• Market challenges / restraints• Detailed market segmentationThe market intelligence report on global radiation therapy in oncology market also highlights that the consumer preference for external beam radiation therapy has been increasing in the past few years, mainly due to advances and the benefits provided the external beam radiation therapy systems. Modern radiation therapy systems such as proton and heavy-ion radiation therapy systems have witnessed increased adoption in developed and emerging economies alike.Some of the key technologies that are expected to have a strong impact on the transformation of the global radiation therapy in oncology market during 2020-2031 include proton and heavy-ion such carbon-ion radiation therapy systems.Market Segmentation• Radiation Systems under different radiation category: External beam radiation systems and internal beam radiation systems are the products covered under radiation therapy market on the basis of radiation type. The internal beam radiation segment is expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the external beam radiation segment accounted for approximately 82.8% of the overall market revenue in 2020.• Products available under different product category: oncology systems such as x-ray and cobalt-60 radiation therapy systems, particle therapy systems such as proton and heavy-ion systems, and others such as software, hybrid systems, among others, are the products covered under radiation therapy market on the basis of product type. The particle therapy systems segment is expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the oncology systems segment accounted for approximately 81.9% of the overall market revenue in 2020.• End users of radiation therapy systems: Hospitals, medical research institutes, and specialized radiotherapy systems (SRCs) are the end-users. The hospitals and medical research institutes segment held the maximum share in the global radiation therapy in oncology market in 2020.• Regions covered: North America, Europe, Asia-Pacific, and Rest-of-the-World. Revenues generated by the U.S. accounted for 50.6% of the global radiation therapy in oncology market revenue in 2020, which was the largest market share in terms of revenue compared to other countries for 2020. The U.S. is expected to remain in the leading position during the forecast period 2021-2031. The U.S. was followed by Germany, France, and Canada.Key Questions Answered:• Which are the consortiums in the radiation therapy market, and what is their role in the market?• How is the funding scenario in the radiation therapy market?• What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?• What is the market trend within the radiation therapy systems industry?• What was the market value of the leading segments of the global radiation therapy in the oncology market in 2020?• How will the industry evolve during the forecast period 2021-2031?• What are the key developmental strategies implemented by the key players to sustain in the competitive market?• What is the current market share of each of the companies in the global radiation therapy in oncology market and what will be their contribution in 2031?• What is the growth potential of radiation therapy in the oncology market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?• What are the key regulatory implications in developed and developing regions for radiation therapy systems and associated procedures?
Companies Mentioned :
Accuray Inc.Eckert & Ziegler AGElekta ABGeneral Electric CompanyHitachi, Ltd.Ion Beam Applications SAKoninklijke Philips N.V.Mevion Medical Systems Inc.TeamBest GroupReflexion Medical Inc.Sensus Healthcare Inc.Varian Medical Systems Inc. (Siemens Healthineers AG)Xoft Inc. (iCAD Inc.)Xstrahl Inc.Zap Surgical Systems Inc.
Press Release :
The global radiation therapy in oncology market is projected to reach $9,206.6 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.0% between 2021 and 2031.BIS Research study indicates that the global radiation therapy in oncology market has witnessed significant growth in the past ten years, owing to adoption of modern radiation therapy systems (proton and heavy-ion radiation therapy systems). Furthermore, advancement in radiation therapy systems for accurately delivering radiation dose to a particular localized treatment area, reducing radiation exposure to healthy tissue and organs, and various therapy procedures availability are some of the prominent factors expected to propel the growth of the radiation therapy in oncology market in the upcoming years.To emphasize the impact of COVID-19 on the global radiation therapy in oncology market, Abdul Wahid, AVP – BIS Research, states, "The COVID-19 pandemic transformed the treatment procedure, shifting from surgery to radiation therapy in possible cases. Also, the introduction of the modern radiation therapy systems such as proton or heavy-ion radiation therapy systems will witness accelerated growth in the radiation therapy market. The pandemic is expected to leave a long-term impact on the global radiation therapy in oncology market, along with the rising awareness of modern treatment availability and there benefits. Apart from the accelerated growth due to the COVID-19 pandemic and new radiation therapy systems, the radiation therapy in oncology market has been witnessing increasing radiotherapy treatment procedures and implementation of new innovation from new market entrants”.Leading companies, market participants, and vendors operating in the market, include, Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., and Zap Surgical Systems Inc., among others.Who should buy this report?• Radiation Therapy Systems manufacturers (emerging and established) to gain a holistic view about the market potential of various systems and software and the developing economies for business expansions.• Established healthcare companies that are integrating software, cloud platform, machine learning, AI, management software, and integrate able imaging modalities with radiation therapy systems manufacturers.• Established technology companies to gain insights about the market potential, market entry strategies, new technologies in the market, and key competitors.How can market intelligence on radiation therapy in oncology market add value to your business’s decision-making process?• Aid in product development.• Aid in understanding the regulatory scenario of the market in different regions.• Help in targeting a segment for launching a new product.• Aid in understanding market potential of different technologies.• Aid in understanding the end-user.• Support in analyzing the market opportunities.• Insights on the key companies in the market.Scope of the Global Radiation Therapy in Oncology Market Report:• Global trends • COVID-19 impact analysis • Available products, and end user segments and respective sub-divisions influencing the market • Study of more than 150 products present in the market.• Detailed competitive landscape• Detailed market share analysis• Study data of over 12 countries• Future perspective of the market• Growth factors• Market challenges / restraints• Detailed market segmentationThe market intelligence report on global radiation therapy in oncology market also highlights that the consumer preference for external beam radiation therapy has been increasing in the past few years, mainly due to advances and the benefits provided the external beam radiation therapy systems. Modern radiation therapy systems such as proton and heavy-ion radiation therapy systems have witnessed increased adoption in developed and emerging economies alike.Some of the key technologies that are expected to have a strong impact on the transformation of the global radiation therapy in oncology market during 2020-2031 include proton and heavy-ion such carbon-ion radiation therapy systems.Market Segmentation• Radiation Systems under different radiation category: External beam radiation systems and internal beam radiation systems are the products covered under radiation therapy market on the basis of radiation type. The internal beam radiation segment is expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the external beam radiation segment accounted for approximately 82.8% of the overall market revenue in 2020.• Products available under different product category: oncology systems such as x-ray and cobalt-60 radiation therapy systems, particle therapy systems such as proton and heavy-ion systems, and others such as software, hybrid systems, among others, are the products covered under radiation therapy market on the basis of product type. The particle therapy systems segment is expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the oncology systems segment accounted for approximately 81.9% of the overall market revenue in 2020.• End users of radiation therapy systems: Hospitals, medical research institutes, and specialized radiotherapy systems (SRCs) are the end-users. The hospitals and medical research institutes segment held the maximum share in the global radiation therapy in oncology market in 2020.• Regions covered: North America, Europe, Asia-Pacific, and Rest-of-the-World. Revenues generated by the U.S. accounted for 50.6% of the global radiation therapy in oncology market revenue in 2020, which was the largest market share in terms of revenue compared to other countries for 2020. The U.S. is expected to remain in the leading position during the forecast period 2021-2031. The U.S. was followed by Germany, France, and Canada.Key Questions Answered:• Which are the consortiums in the radiation therapy market, and what is their role in the market?• How is the funding scenario in the radiation therapy market?• What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?• What is the market trend within the radiation therapy systems industry?• What was the market value of the leading segments of the global radiation therapy in the oncology market in 2020?• How will the industry evolve during the forecast period 2021-2031?• What are the key developmental strategies implemented by the key players to sustain in the competitive market?• What is the current market share of each of the companies in the global radiation therapy in oncology market and what will be their contribution in 2031?• What is the growth potential of radiation therapy in the oncology market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?• What are the key regulatory implications in developed and developing regions for radiation therapy systems and associated procedures?
Headline :
Global Radiation Therapy in the Oncology Market to Reach $9,206.6 Million by 2031
Table of Contents :
1 Market Definition1.1 Assumptions and Limitations1.2 Market Forecasting Factors2 Markets2.1 Market Introduction2.2 Key Findings and Opportunity Assessment2.3 Global Market Outlook2.4 Regulatory Framework2.4.1 U.S.2.4.2 Europe2.4.3 Japan2.4.4 China2.4.5 Other Consortiums2.5 Distribution and Marketing Strategies2.5.1 Case Study: Elekta AB2.5.2 Case Study: Varian Medical Systems Inc. (Siemens Healthineers AG)2.6 Impact of COVID-19 Pandemic on the Market2.7 Key Developments and Strategies2.7.1 Partnerships, Alliances, and Business Expansion Activities2.7.2 Regulatory and Legal Activities2.7.3 Product Launches and Upgradation2.7.4 Funding Activities2.7.5 Mergers and Acquisition Activities2.8 Market Share Analysis2.8.1 by Radiation Type2.8.2 by Product Type2.8.3 by Therapy2.8.4 by End User2.8.5 by Region2.9 Market Dynamics2.9.1 Overview2.9.2 Impact Analysis2.9.3 Market Drivers2.9.3.1 Rising Incidence and Prevalence of Neoplastic Patients and Elevating Geriatric Population2.9.3.2 Rising Demand for Reduced Radiation Exposure During Radiotherapy2.9.3.3 Technological Advancements in the Field of Radiotherapy2.9.4 Market Restraints2.9.4.1 High Cost of Radiotherapy Systems and their Associated Procedures2.9.4.2 Highly Regulated Market Due to the Use of Radiation2.9.5 Market Opportunities2.9.5.1 Development of Low-Cost Cancer Treatment Center2.9.5.2 Implementation of Machine Learning in Radiotherapy Systems2.9.6 Market Trend2.9.6.1 Integration of MRI or CT Technology with Radiotherapy Systems2.9.6.2 Adoption of Radiation Therapy by Emerging Countries2.1 Analyst Perspective2.11 Epidemiology Assessment3 Application3.1 Radiation Type3.1.1 Market Overview3.1.2 Market Attractiveness Analysis3.1.3 Market Size and Forecast3.1.3.1 External Beam Radiation3.1.3.2 Internal Beam Radiation3.2 Therapy3.2.1 Market Overview3.2.2 Market Attractiveness Analysis3.2.3 Market Size and Forecast3.2.3.1 Stereotactic Radiosurgery3.2.3.2 Image-Guided Radiation Therapy3.2.3.3 Intensity-Modulated Radiation Therapy3.2.3.4 Volumetric-Modulated Arc Therapy3.2.3.5 Brachytherapy3.3 End User3.3.1 Market Overview3.3.2 Market Attractiveness Analysis3.3.3 Market Size and Forecast3.3.3.1 Hospitals and Medical Research Institutes3.3.3.2 Specialized Radiotherapy Centers4 Products4.1 Market Overview4.2 Market Attractiveness Analysis4.2.1 Market Size and Forecast4.2.1.1 Oncology Systems4.2.1.2 Particle Therapy Systems (Proton and Heavy Ion)4.2.1.3 Others5 Region5.1 Market Overview5.1.1 Market Attractiveness Analysis5.2 North America5.2.1 Overview5.2.1.1 Market Size and Forecast5.2.1.1.1 Radiation Type5.2.1.1.2 Product Type5.2.1.1.3 Country5.2.1.1.3.1 U.S.5.2.1.1.3.2 Canada5.3 Europe5.3.1 Overview5.3.1.1 Market Size and Forecast5.3.1.1.1 Radiation Type5.3.1.2 Product Type5.3.1.3 by Country5.3.1.3.1 Germany5.3.1.3.2 France5.3.1.3.3 Italy5.3.1.3.4 U.K.5.3.1.3.5 Spain5.3.1.3.6 Rest-of-Europe5.4 Asia-Pacific5.4.1 Overview5.4.1.1 Market Size and Forecast5.4.1.2 Radiation Therapy5.4.1.3 Product Type5.4.1.4 Country5.4.1.4.1 Japan5.4.1.4.2 China5.4.1.4.3 India5.4.1.4.4 South Korea5.4.1.4.5 Australia and New Zealand5.4.1.4.6 Rest-of-Asia-Pacific5.5 Rest-of-the-World5.5.1 Overview5.5.1.1 Market Size and Forecast5.5.1.2 Radiation Type5.5.1.3 Product Type6 Markets - Competitive Benchmarking & Company Profiles6.1 Overview6.1.1 Key Players: Snapshot6.1.2 Key Strategies Implemented by Market Players6.2 Accuray Inc.6.2.1 Company Overview6.2.2 Role of the Company in the Market6.2.3 Financials6.2.4 SWOT Analysis6.3 Eckert & Ziegler AG6.3.1 Company Overview6.3.2 Role of the Company in the Market6.3.3 Financials6.3.4 SWOT Analysis6.4 Elekta AB6.4.1 Company Overview6.4.2 Role of the Company in the Market6.4.3 Financials6.4.4 SWOT Analysis6.5 General Electric Company6.5.1 Company Overview6.5.2 Role of the Company in the Market6.5.3 Financials6.5.4 SWOT Analysis6.6 Hitachi, Ltd.6.6.1 Company Overview6.6.2 Role of the Company in the Market6.6.3 Financials6.6.4 SWOT Analysis6.7 Ion Beam Applications SA6.7.1 Company Overview6.7.2 Role of the Company in the Market6.7.3 Financials6.7.4 SWOT Analysis6.8 Koninklijke Philips N.V.6.8.1 Company Overview6.8.2 Role of the Company in the Market6.8.3 Financials6.8.4 SWOT Analysis6.9 Mevion Medical Systems Inc.6.9.1 Company Overview6.9.2 Role of the Company in the Market6.9.3 SWOT Analysis6.1 TeamBest Group6.10.1 Company Overview6.10.2 Role of the Company in the Market6.10.3 SWOT Analysis6.11 Reflexion Medical Inc.6.11.1 Company Overview6.11.2 Role of the Company in the Market6.11.3 SWOT Analysis6.12 Sensus Healthcare Inc.6.12.1 Company Overview6.12.2 Role of the Company in the Market6.12.3 Financials6.12.4 SWOT Analysis6.13 Varian Medical Systems Inc. (Siemens Healthineers AG)6.13.1 Company Overview6.13.2 Role of the Company in the Market6.13.3 Financials6.13.4 SWOT Analysis6.14 Xoft Inc. (iCAD Inc.)6.14.1 Company Overview6.14.2 Role of the Company in the Market6.14.3 Financials6.14.4 SWOT Analysis6.15 Xstrahl Inc.6.15.1 Company Overview6.15.2 Role of the Company in the Market6.15.3 SWOT Analysis6.16 Zap Surgical Systems Inc.6.16.1 Company Overview6.16.2 Role of the Company in the Market6.16.3 SWOT Analysis7 Research Methodology7.1 Primary Research7.2 Secondary Research7.3 Data Sources and Categorization7.4 Market Estimation and Forecast Methodology7.4.1 Top-Down Approach7.4.2 Bottom-Up Approach7.5 Data TriangulationList of Figures Figure 1: Global Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 2: Dominating Segments of Global Radiation Therapy in the Oncology Market, 2020 and 2031Figure 3: Global Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020, 2026, and 2031Figure 4: Global Radiation Therapy in the Oncology Market (by Product Type), 2020, 2026, and 2031Figure 5: Global Radiation Therapy in the Oncology Market (by Therapy), 2020, 2026, and 2031Figure 6: Global Radiation Therapy in the Oncology Market (by End User), $Million, 2020, 2026, and 2031Figure 7: Global Radiation Therapy in the Oncology Market (by Region), $Million, 2020 and 2031Figure 8: Share of Key Developments and Strategies (by Category), January 2017-March 2021Figure 9: Figure: Global Radiation Therapy in the Oncology: Market SegmentationFigure 10: Global Radiation Therapy in the Oncology Market: Incremental Revenue Opportunity, $Million, 2020-2031Figure 11: Global Radiation Therapy in the Oncology Market Scenario, $Million, 2020-2031Figure 12: Regulatory Process for Medical Devices in the U.S.Figure 13: MDR Transitional Provisions (EU)Figure 14: Regulatory Process for Medical Devices in European UnionFigure 15: Regulatory Process for Medical Devices in ChinaFigure 16: Global Radiation Therapy in the Oncology Market: Key Developments and Strategies, January 2017-May 2021Figure 17: Share of Key Developments and Strategies in the Global Radiation Therapy in the Oncology Market (by Category), January 2017-May 2021Figure 18: Global Radiation Therapy in the Oncology Market – Key Partnerships, Alliances, and Business Expansion Activities, (by Company), 2017-2021Figure 19: Global Radiation Therapy in the Oncology Market – Key Regulatory and Legal Activities, 2017-2021Figure 20: Global Radiation Therapy in the Oncology Market – Key New Offerings, 2017-2021Figure 21: Global Radiation Therapy in the Oncology Market – Key Funding Activities, 2017-2021Figure 22: Global Radiation Therapy in the Oncology Market, Funding Scenario, $Million, 2005-2021Figure 23: Global Radiation Therapy in the Oncology Market – Key Mergers and Acquisition Activities, 2017-2021Figure 24: Global Radiation Therapy in the Oncology Market (by Radiation Type), 2020Figure 25: Global Radiation Therapy in the Oncology Market (by Product Type), 2020Figure 26: Global Radiation Therapy in the Oncology Market (by Therapy), 2020Figure 27: Global Radiation Therapy in the Oncology Market (by End User), 2020Figure 28: Global Radiation Therapy in the Oncology Market (by Region), 2020Figure 29: Market DynamicsFigure 30: Rising Incidence of Neoplastic Persons (Worldwide), 2010-2031Figure 31: Rising Prevalence of Neoplastic Persons (Worldwide) (by Age Group), 2010-2031Figure 32: Relative Dose vs. Tissue Depth for Various Particle and Photon BeamsFigure 33: Rising Incidence, Prevalence, and Deaths Caused by Neoplasm (Global), 2010-2019Figure 34: Market Segmentation: by Radiation TypeFigure 35: Pros and Cons of External and Internal Beam RadiationFigure 36: Global Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031Figure 37: Market Attractiveness Analysis (by Radiation Type), 2020-2031Figure 38: Benefits of Modern External Beam Radiation TherapyFigure 39: Global Radiation Therapy in the Oncology Market (External Beam Radiation), $Million, 2020-2031Figure 40: Benefits of Modern Internal Beam Radiation TherapyFigure 41: Global Radiation Therapy in the Oncology Market (Internal Beam Radiation), $Million, 2020-2031Figure 42: Market Segmentation: by TherapyFigure 43: Market Attractiveness Analysis (by Therapy), 2020-2031Figure 44: Global Radiation Therapy in the Oncology Market (SRS), $Million, 2020-2031Figure 45: Global Radiation Therapy in the Oncology Market (IGRT), $Million, 2020-2031Figure 46: Global Radiation Therapy in the Oncology Market (IMRT), $Million, 2020-2031Figure 47: Global Radiation Therapy in the Oncology Market (VMAT), $Million, 2020-2031Figure 48: Global Radiation Therapy in the Oncology Market (Brachytherapy), $Million, 2020-2031Figure 49: Market Segmentation: by End UserFigure 50: Global Radiation Therapy in the Oncology Market (by End User), $Million, 2020-2031Figure 51: Market Attractiveness Analysis (by End User), 2020-2031Figure 52: Global Radiation Therapy in the Oncology Market (Hospitals and Medical Research Institutes), $Million, 2020-2031Figure 53: Global Radiation Therapy in the Oncology Market (SRCs), $Million, 2020-2031Figure 54: Market Segmentation: by Product TypeFigure 55: Global Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031Figure 56: Market Attractiveness Analysis (by Product Type), 2020-2031Figure 57: Global Radiation Therapy in the Oncology Market (Oncology Systems), $Million, 2020-2031Figure 58: Global Radiation Therapy in the Oncology Market (Particle Therapy Systems (Proton and Heavy Ion)), $Million, 2020-2031Figure 59: Global Radiation Therapy in the Oncology Market (Others), $Million, 2020-2031Figure 60: Global Radiation Therapy in the Oncology Market Scenario (by Region), 2020 and 2031Figure 61: Global Radiation Therapy in the Oncology Market (by Region), 2020 and 2031Figure 62: Market Attractiveness Analysis (by Region), 2020-2031Figure 63: North America Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 64: North America Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031Figure 65: North America Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031Figure 66: North America Radiation Therapy in the Oncology Market (by Country), 2020-2031Figure 67: U.S. Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 68: Canada Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 69: Europe Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 70: Europe Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031Figure 71: Europe Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031Figure 72: Europe Radiation Therapy in the Oncology Market (by Country), 2020-2031Figure 73: Germany Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 74: France Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 75: Italy Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 76: U.K. Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 77: Spain Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 78: Rest-of-Europe Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 79: Asia-Pacific Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 80: Asia-Pacific Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031Figure 81: Asia-Pacific Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031Figure 82: Asia-Pacific Radiation Therapy in the Oncology Market (by Country), 2020-2031Figure 83: Japan Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 84: China Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 85: India Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 86: South Korea Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 87: Australia and New Zealand Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 88: Rest-of-Asia-Pacific Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 89: Rest-of-the-World Radiation Therapy in the Oncology Market, $Million, 2020-2031Figure 90: Rest-of-the-World Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031Figure 91: Rest-of-the-World Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031Figure 92: Total Number of Companies ProfiledFigure 93: Accuray, Inc.: Overall Financials, $Million, 2018-2020Figure 94: Accuray Inc.: Net Revenue (by Product Type), $Million, 2018-2020Figure 95: Accuray Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 96: Eckert & Ziegler Group: Overall Financials, $Million, 2018-2020Figure 97: Eckert & Ziegler Group: Net Revenue (by Product Type), $Million, 2018-2020Figure 98: Eckert & Ziegler Group: Net Revenue (by Region), $Million, 2018-2020Figure 99: Elekta AB: Overall Financials, $Million, 2018-2020Figure 100: Elekta AB: Net Revenue (by Product Type), $Million, 2018-2020Figure 101: Elekta AB: Net Revenue (by Region), $Million, 2018-2020Figure 102: General Electric Company: Overall Financials, $Million, 2018-2020Figure 103: General Electric Company: Net Revenue (by Product Type), $Million, 2018-2020Figure 104: General Electric Company (by Healthcare Segment), $Million, 2018-2020Figure 105: General Electric Company: Net Revenue (by Region), $Million, 2018-2020Figure 106: Hitachi, Ltd.: Overall Financials, $Million, 2018-2020Figure 107: Hitachi, Ltd.: Net Revenue (by Product Type), $Million, 2018-2020Figure 108: Hitachi, Ltd.: Net Revenue (by Region), $Million, 2018-2020Figure 109: Ion Beam Applications Group: Overall Financials, $Million, 2018-2020Figure 110: Ion Beam Applications Group: Net Revenue (by Product Type), $Million, 2018-2020Figure 111: Ion Beam Applications Group: Net Revenue (Medical Devices) (by Region), $Million, 2018-2020Figure 112: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020Figure 113: Koninklijke Philips N.V.: Net Revenue (by Product Type), $Million, 2018-2020Figure 114: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020Figure 115: Sensus Healthcare Inc.: Overall Financials, $Million, 2018-2020Figure 116: Sensus Healthcare Inc.: Net Revenue (by Product Type), $Million, 2018-2020Figure 117: Sensus Healthcare Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 118: Varian Medical Systems Inc.: Overall Financials, $Million, 2018-2020Figure 119: Varian Medical Systems Inc.: Net Revenue (by Product Type), $Million, 2018-2020Figure 120: Varian Medical Systems Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 121: iCAD Inc.: Overall Financials, $Million, 2018-2020Figure 122: iCAD Inc.: Net Revenue (by Product Type), $Million, 2018-2020Figure 123: Figure: iCAD Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 124: Research MethodologyFigure 125: Primary ResearchFigure 126: Secondary ResearchFigure 127: Top-Down ApproachFigure 128: Bottom-Up ApproachFigure 129: Data TriangulationList of Tables Table 1: Global Radiation Therapy in the Oncology Market: Impact AnalysisTable 2: Global Radiation Therapy in the Oncology Market: Forecasting FactorsTable 3: Other Organizations/AssociationsTable 4: Impact Analysis: Market DriversTable 5: Impact Analysis: Market RestraintsTable 6: Number and Distribution of Persons Aged 60 Years or Over (by Region), 2017 and 2050Table 7: Incidence and Distribution of Different Neoplasm, Million, 2010-2019Table 8: Global Radiation Therapy in the Oncology Market (by Therapy), $Million, 2020-2031Table 9: Key Players: SnapshotTable 10: Key Strategies Implemented by Key Market Players (January 2017-May 2021)Table 11: Eckert & Ziegler Group: Net Revenue (by Product Category), $Million, 2018-2020Table 12: Ion Beam Applications Group: Net Revenue (by Product Category), $Million, 2018-2020Table 13: Varian Medical Systems Inc.: Net Revenue (by Sales Category), $Million, 2018-2020Table 14: Varian Medical Systems Inc.: Net Revenue (by Region), $Million, 2018-2020Table 15: iCAD Inc.: Net Revenue (by Product Category), $Million, 2018-2020